About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology
Free SOHO Membership:
www.sohoonline.org
SOHO 2023
Leukemia
Lymphoma
Myeloma
MDS and MPN
Videos
SOHO 2022
Myeloma
Lymphoma
Leukemia
MDS and MPN
Benign Hematology
SOHO 2021
Myeloma
Cellular Therapy
Solid Tumors
Leukemia
MDS
Benign Hematology
MPN
Lymphoma
SOHO 2020
Basic Science
Lymphoma
Leukemia
Myeloma
MDS and MPN
Benign Hematology
SOHO Highlights: State of the Art and Next Questions
SOHO 2019
Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
SOHO 2018
Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Session VI: Multiple Myeloma
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics
Plenary Sessions
Breakfast with the Expert
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
G
SOHO 2021: The Next Wave of Novel Agents in Aggressive B-Cell Lymphoma
By
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
FEATURING
Gilles Salles
By
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
FEATURING
Gilles Salles
13 views
September 30, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Lymphoma
10:57
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Addressing an Unmet Need in Indolent B-Cell Lymphoma: Beyo…
Feat.
J. Trotman
12:37
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Next Questions in T-Cell Lymphoma
Feat.
B. Pro
11:25
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Next Questions in Hodgkin Lymphoma
Feat.
C. Moskowitz
10:24
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on Optimal Treatment of MCL: Future Strategies
Feat.
M. Dreyling
13:14
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Next Questions in Cellular Therapy
Feat.
M. Maus
10:34
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Next Questions in Aggressive B-Cell Lymphoma
Feat.
G. Nowakowski
13:29
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: New Pathways and New Targets in PTCL
Feat.
R. Wilcox
14:16
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Moving Beyond BV-CHP in PTCL
Feat.
N. Mehta-Shah
21:21
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Treatment Updates on Advanced CTCL
Feat.
L. Pinter-Brown
14:34
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Immunotherapy Approaches in T-Cell Lymphoma
Feat.
M. Mamonkin
15:47
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Disparities in Treatment in Patients With T-Cell Lymphoma
Feat.
M. Lechowicz
13:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 5-Year Results of A+CHP vs. CHOP in 1L CD30-Positive PTCL…
Feat.
S. Iyer
14:45
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on the Progress in Hodgkin Lymphoma: From Biolo…
Feat.
S. Ansell
16:04
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Integrating Novel Agents Into the Treatment of Classic HL
Feat.
A. LaCasce
18:54
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Treatment Strategies in Nodular Lymphocyte Predominant HL
Feat.
R. Advani
18:02
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Molecular Pathogenesis of FL and Its Relevance to Clinica…
Feat.
J. Okosun
17:56
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Sequencing Therapy in Follicular Lymphoma
Feat.
P. Martin
16:38
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on Novel Therapies in Indolent Lymphoma
Feat.
L. Nastoupil
14:35
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 CAR T-Cell Therapy in Indolent Lymphoma
Feat.
C. Jacobson
11:31
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on Treatment-Naïve Waldenström Macroglobulinemia: A…
Feat.
J. Abeykoon
14:13
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on Dissecting the Biology of DLBCL: How Close A…
Feat.
G. Lenz
18:33
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Innovative Approaches in Untreated DLBCL
Feat.
J. Westin
15:47
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Sequencing Therapies in Transplant-Ineligible DLBCL
Feat.
L. Sehn
12:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: The Next Wave of Novel Agents in Aggressive B-Cell Lympho…
Feat.
G. Salles
15:58
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Updates on Primary Mediastinal B-Cell Lymphoma: Surveying …
Feat.
K. Dunleavy
25:03
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on High Grade B-Cell Lymphoma: Double/Triple Hi…
Feat.
A. Davies
04:54
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Data on Loncastuximab Tesirine in R/R DLBCL: LOTIS-2 Follo…
Feat.
B. Kahl
11:20
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on Heavily Pretreated R/R NHL Patients: Updated…
Feat.
C. Khan
15:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Update on Dissecting the Biology of MCL: What Is Clinicall…
Feat.
T. Witzig
16:39
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update: Tailoring Upfront Therapy in MCL
Feat.
B. Kahl
16:22
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Novel Treatment Approaches in R/R MCL
Feat.
K. Maddocks
13:55
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on CAR T-Cell Therapy in MCL
Feat.
M. Wang
10:22
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Highlights on Tailoring Therapy in Waldenstrom Macroglobul…
Feat.
J. Castillo
14:22
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Update on the New Agents in Marginal Zone Lymphoma
Feat.
P. Zinzani
13:47
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: What Can We Learn From a Single Case of ENMZL With Multip…
Feat.
I. Lossos
11:27
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on CD19-Directed CAR T-Cell Therapy in B-Cell Lymph…
Feat.
F. Locke
20:30
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on the Management of DLBCL Post-CAR T-Cell Ther…
Feat.
J. Abramson
10:19
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on Primary CNS Lymphoma: Prognostic Factors, Di…
Feat.
L. Nayak
15:50
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Prophylaxis and Management of Secondary CNS Lymphoma
Feat.
M. Roschewski
13:50
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Prognostication and Treatment of Burkitt Lymphoma in the …
Feat.
A. Olszewski
11:41
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 on R/R PTCL: Multiagent Cytotoxic Chemo vs. Single Agent, …
Feat.
P. Porcu
16:55
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 on Hodgkin Lymphoma: What to Do When Checkpoint Inhibitors…
Feat.
P. Armand
15:29
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 on POD24 in Follicular Lymphoma: What Time Has Taught Us
Feat.
N. Fowler
